Dietary Restrictions and Drug Interactions With Monoamine Oxidase Inhibitors: An Update
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
onoamine oxidase inhibitors (MAOIs) are effective antidepressants, but their use has been limited by potentially fatal food and drug interactions.A clearer understanding of these interactions and the mechanism of action of these drugs, as well as knowledge of new formulations and delivery methods of MAOIs, could help clinicians make more use of this class of antidepressant.The MAOIs are effective for depression with atypical features 1 and depression that is treatment resistant.2 Although indicated by some guidelines 3 to treat these conditions, MAOIs are still underused.4 A main reason for reluctance to use MAOIs is due to the dietary and drug restrictions, which are required because food and drug interactions can cause serious and potentially fatal adverse events, such as hypertensive crisis and serotonin syndrome.Newer formulations of MAOIs that have mechanisms of action different from those of older MAOIs may lessen the risk for these adverse effects and make this class of antidepressants worth reconsidering for some patients with depression. MechanisM of action of MaoisThe propensity for food and drug interactions of MAOIs is related to their mechanisms of action.The MAOIs inhibit monoamine oxidase (MAO), an enzyme that catalyzes the oxidative removal of monoamines, including serotonin, histamine, and the catecholamines dopamine, norepinephrine, and epinephrine, as well as trace amines.5 By covalently bonding to MAO enzymes, MAOIs prevent the removal of these From the Indiana Institute for Personalized Medicine and the Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis.This article is derived from the planning teleconference series "A Fresh Look at Monoamine Oxidase Inhibitors for Depression, " which was held December 2011 through February 2012 and supported by an educational grant from Mylan Specialty L.P. (formerly known as Dey Pharma, L.P.).Dr Flockhart has no personal affiliations or financial relationships with any commercial interest to disclose relative to this article.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treatment of depression with atypical features: a meta-analytic approach
Henkel, V., Mergl, R., Allgaier, A.-K., Kohnen, R., Möller, H.-J., & Hegerl, U. (2006) · Psychiatry Research · doi:10.1016/j.psychres.2005.07.012 · Cited by 161
Cited by
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Health, T. L. G. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30432-0 · Cited by 417
“It can occur when people taking MAOIs ingest food or drinks with tyramine, such as but not limited to sausage, alcohol, yogurt, aged cheese, and anything with monosodium glutamate.(8) Combining MAOIs with nasal and sinus decongestants can also cause hypertensive crisis.”
Biogenic Amines in Dairy Products
Linares, D. M., Martín, M., Ladero, V., Alvarez, M. A., & Fernández, M. (2011) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2011.582813 · Cited by 399
Gillman, P. K. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1932-y · Cited by 255
Revisiting the Monoamine Hypothesis of Depression: A New Perspective
Goldberg, J. S., Bell, C. E., & Pollard, D. A. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s11375 · Cited by 45
Metadata
- Authors
- Flockhart, D. A.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2012-07
- Volume
- 73
- Issue
- suppl 1
- Pages
- 17-24
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2048077192
- Cited by
- 98
- References
- 1
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.